Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Double-Blind Comparison of an Alpha-1 Proteinase Inhibitor (Kamada API) With a Currently Marketed API Product in Individuals With Alpha-1 Antitrypsin Deficiency

NCT00460096 is registered in ClinicalTrials.gov with Kamada, Ltd. as lead sponsor.

NCT NCT00460096
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00460096 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Double-Blind Comparison of an Alpha-1 Proteinase Inhibitor (Kamada API) With a Currently Marketed API Product in Individuals With Alpha-1 Antitrypsin Deficiency
Lead sponsor
Kamada, Ltd.
Phase
Phase 2/3
Overall status
Completed
Start date
March 31, 2007
Completion date
September 30, 2007
Enrollment
50 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

alpha 1-antitrypsin deficiency